Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBW-004285 for postoperative abdominal analgesia
ChiCTR2600120719Phase 2Not yet recruiting
- Sponsor
- The Third Xiangya Hospital of Central South University, Sichuan Provincial People's Hospital
- Start
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HBW-004285 in postoperative pain (8 arms), sponsored by The Third Xiangya Hospital of Central South University, Sichuan Provincial People's Hospital. Primary endpoint: Sum of pain intensity difference at resting between 0 and 48 hours after the first dose (SPIDr0-48). Planned start Mar 2026; status: not yet recruiting.
02
Drugs
HBW-004285
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600120719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600120719.